Innovation-driven trend shaping COVID-19 vaccine development in China

Area of Science:

• Vaccinology and Virology
• Public Health
• Infectious Disease Research

Background:

• The Coronavirus disease 2019 (COVID-19) pandemic necessitated rapid development of countermeasures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
• China has played a significant role in addressing SARS-CoV-2 transmission and mutation through innovative platforms.
• Vaccines targeting the spike protein or using inactivated whole virus are crucial for public health interventions.

Purpose of the Study:

• To outline representative COVID-19 vaccine strategies developed in China.
• To summarize the advantages and disadvantages of current vaccine approaches.
• To explore new technologies for enhanced immunity against SARS-CoV-2 variants.

Main Methods:

• Review of existing vaccine platforms, including spike protein-based and inactivated virus vaccines.
• Analysis of various administration routes for vaccine delivery.
• Evaluation of emerging technologies for vaccine development.

Main Results:

• Several innovative vaccine platforms have been developed to combat SARS-CoV-2.
• Existing strategies offer varying degrees of protection and face challenges.
• New technologies show potential for broader and more potent immune responses.

Conclusions:

• Continued innovation in vaccine development is essential for durable protection against COVID-19.
• Developing effective vaccines based on virus properties remains a priority to combat hypermutated SARS-CoV-2 variants.
• A robust and resilient approach to infectious disease is paramount.